Abstract:AIM: To clone flagellin genes A (flaA) and B (flaB) from a clinical strain of Helicobacter pylori(Hpylori) and to construct prokaryotic expression systems of the genes and identify immunity of the fusion proteins.METHODS: The flaA and flaB genes from a clinical Hpylori isolate Y06 were amplified by high fidelity PCR. The nucleotide sequences of target DNA amplification fragments from the two genes were sequenced after T-A cloning. The recombinant expression vector pET32a inserted with flaA and flaB genes was constructed, respectively. The expressions of FlaA and FlaB fusion proteins in E. coli BL21DE3 induced by isopropylthio-p-D-galactoside (IPTG) at different concentrations were examined by SIDS-PAGE. Western blot using commercial antibodies against whole cell of H pylori and immunodiffusion assay using self-prepared rabbit antiserum against FlaA (rFlaA) or FlaB (rFlaB) recombinant proteins were applied to the determination of the fusion proteins immunity. ELISA was used to detect the antibodies against rFlaA and rFlaB in sera of 125 Hpylori infected patients and to examine rFlaA and rFlaB expression in 98 clinical isolates of H pylori, respectively.RESULTS: In comparison with the reported corresponding sequences, the nucleotide sequence homologies of the cloned flaA and flaB genes were from 96.28-97.13% and 96.31-97.73%, and their putative amino acid sequence homologies were 99.61-99.80% and 99.41-100% for the two genes, respectively. The output of rFlaA and rFlaB expressed by pET32a-flaA-BL21DE3 and pET32J-flaB-BL21DE3 systems was as high as 40-50% of the total bacterial proteins. Both rFlaA and rFlaB were able to combine with the commercial antibodies against whole cell of Hpylori and to induce rabbits to produce specific antibodies with the same 1:2 immunodiffusion titers after the animals were immunized with the two recombinant proteins. Ninety-eight and zero point 4 and 92.80% of the serum samples from 125 patients infected with Hpylori were positive for rFlaA and rFlaB antibodies, respectively. One hundred percent and 98.98% of the 98 tested isolates of H pylori were detectable for rFlaA and rFlaB epitopes, respectively.CONCLUSION: Two prokaryotic expression systems with high efficiency of H pylori flaA and flaB genes were successfully established. The expressed rFlaA and rFlaB showed satisfactory immunoreactivity and antigenicity. High frequencies of FlaA and FlaB expression in different Hpylori clinical strains and the general existence of specific antibodies against FlaA and FlaB in Hpylori infected patients strongly indicate that FlaA and FlaB are excellent antigen candidates for developing H pylori vaccine.

Purification of Recombinant Aer Toxin and Antigenicity Analysis

Purification and characterization of Aeromonas hydrophila beta-hemolysin

Crude Extraction and Purification of IgY Against Aeromonas Hydrophila and Its Antibacterial Activity in Vitro

Extraction and Purification of IgY against Aeromonas Hydrophila from Egg Yolk

Purification and partial characterization of a cytotonic enterotoxin produced by Aeromonas hydrophila

Purification and characterization of enterotoxin produced by Aeromonas sobria

Construction of Expression Systems for Flaa and Flab Genes of Helicobacter Pylori and Determination of Immunoreactivity and Antigenicity of Recombinant Proteins.

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Bioactivity and immunological characterization of a cholera toxin-cross-reactive cytolytic enterotoxin from Aeromonas hydrophila

Renaturation and Purification of ApxII Toxin of Actinobacillus Pleuropneumoniae

Development of an Aeromonas hydrophila recombinant extracellular protease vaccine

High-Level Expression, Purification, Polyclonal Antibody Preparation Against Recombinant Oprd from Pseudomonas Aeruginosa

Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila

Production of an enterotoxin by a gastro-enteritis-associated Aeromonas strain

Construction of Hpaa Gene from A Clinical Isolate of Helicobacter Pylori and Identification of Fusion Protein

A Novel Approach to Development of Monoclonal Antibodies Using Native Antigen for Immunization and Recombinant Antigen for Screening.

Cloning and Expression of Fragment with 2148 Bp from Caga Gene from Isolates of a Helicobacter Pylori and Identification of Immunogenicity of the Recombinant Proteins

The Immune Response and Protective Efficacy of Vaccination with Oral Microparticle Aeromonas Sobria Vaccine in Mice

Incidence and Toxigenicity of Aeromonas Species in Retail Poultry, Beef and Pork

Amino-acid residues involved in biological functions of the cytolytic enterotoxin from Aeromonas hydrophila

Preparation of polyclonal antibodies against chemically synthesized ApxIA and ApxIVA toxins and their diagnostic efficacy in the experimentally injected mice